V. Aragón

Comparison of paclitaxel-eluting stents (Taxus) and everolimus-eluting stents (Xience) in left main coronary artery disease with 3 years follow-up (from the ESTROFA-LM registry).

M. Masotti, F. Alfonso, R. Calviño, 2013, The American journal of cardiology.

Drug-eluting vs. conventional balloon for side branch dilation in coronary bifurcations treated by provisional T stenting.

V. Aragón, Juan A. Herrador, Juan C. Fernandez, 2013, Journal of interventional cardiology.

Comparison of zotarolimus‐ versus everolimus‐eluting stents in the treatment of coronary bifurcation lesions

V. Aragón, Juan A. Herrador, Juan C. Fernandez, 2011, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Ischemia: substrate or trigger?

E. Díaz-Infante, R. Cózar, V. Aragón, 2013, Revista espanola de cardiologia.

Unprotected left main coronary artery stenting with everolimus (Xience V) drug-eluting stents: A single center retrospective experience

J. C. Fernández-Guerrero, V. Aragón, C. Adamuz, 2013 .

The TITAN-AMI multicenter registry evaluating the usage of Titan2 stent in patients with ST segment elevation myocardial infarction. Final result at 12-month follow-up.

J. Mauri, J. Bassaganyas, J. Goicolea, 2015, Minerva Cardioangiologica : a Journal on Cardiovascular Pathophysiology, Clinical Medicine and Therapy.